Wed, June 29, 2022
Tue, June 28, 2022
Mon, June 27, 2022
Fri, June 24, 2022
Thu, June 23, 2022
Wed, June 22, 2022

Derek Archila Initiated (BPMC) at Sell and Held Target at $40 on, Jun 27th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. sell-and-held-target-at-40-on-jun-27th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Wells Fargo, Initiated "Blueprint Medicines Corporation" (BPMC) at Sell and Held Target at $40 on, Jun 27th, 2022.

Derek has made no other calls on BPMC in the last 4 months.



There are 6 other peers that have a rating on BPMC. Out of the 6 peers that are also analyzing BPMC, 3 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $65 on, Tuesday, June 14th, 2022
  • Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $60 on, Monday, June 13th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $65 on, Thursday, May 19th, 2022


These are the ratings of the 3 analyists that currently disagree with Derek


  • David Lebowitz of "Citigroup" Downgraded from Hold to Strong Sell and Decreased Target to $41 on, Friday, June 10th, 2022
  • Eun Yang of "Jefferies" Upgraded from Hold to Strong Buy and Decreased Target to $78 on, Wednesday, June 1st, 2022
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $105 on, Friday, March 4th, 2022